JP2018527903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527903A5 JP2018527903A5 JP2018502692A JP2018502692A JP2018527903A5 JP 2018527903 A5 JP2018527903 A5 JP 2018527903A5 JP 2018502692 A JP2018502692 A JP 2018502692A JP 2018502692 A JP2018502692 A JP 2018502692A JP 2018527903 A5 JP2018527903 A5 JP 2018527903A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- binding fragment
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562195504P | 2015-07-22 | 2015-07-22 | |
| US62/195,504 | 2015-07-22 | ||
| US201662275068P | 2016-01-05 | 2016-01-05 | |
| US62/275,068 | 2016-01-05 | ||
| PCT/US2016/043712 WO2017015622A2 (en) | 2015-07-22 | 2016-07-22 | Gdf11 binding proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527903A JP2018527903A (ja) | 2018-09-27 |
| JP2018527903A5 true JP2018527903A5 (enExample) | 2019-10-17 |
Family
ID=57834686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018502692A Pending JP2018527903A (ja) | 2015-07-22 | 2016-07-22 | Ｇｄｆ１１結合タンパク質およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180208648A1 (enExample) |
| EP (1) | EP3324996A4 (enExample) |
| JP (1) | JP2018527903A (enExample) |
| AU (1) | AU2016297248A1 (enExample) |
| CA (1) | CA3031430A1 (enExample) |
| WO (1) | WO2017015622A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| AU2017296040C1 (en) | 2016-07-15 | 2023-06-22 | Acceleron Pharma Inc. | Compositions and methods for treating pulmonary hypertension |
| MA47163A (fr) * | 2016-12-16 | 2019-11-06 | Biogen Ma Inc | Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé |
| US20200155481A1 (en) * | 2017-05-03 | 2020-05-21 | The Johns Hopkins University | Intramuscular atovaquone for malaria prophylaxis |
| KR20220066413A (ko) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| KR102646145B1 (ko) | 2018-05-31 | 2024-03-11 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물 |
| JP7540994B2 (ja) | 2018-07-11 | 2024-08-27 | スカラー ロック インコーポレイテッド | 高親和性のアイソフォーム選択的ＴＧＦβ１阻害剤、およびその使用 |
| PT3677278T (pt) | 2018-07-11 | 2022-02-03 | Scholar Rock Inc | Inibidores seletivos da isoforma tgfbeta1 e sua utilização |
| CA3106669A1 (en) * | 2018-07-20 | 2020-01-30 | Momenta Pharmaceuticals, Inc. | Compositions of fcrn antibodies and methods of use thereof |
| KR102058961B1 (ko) | 2018-07-28 | 2019-12-24 | 주식회사 엑소코바이오 | 엑소좀의 동결건조 방법 |
| KR102163806B1 (ko) * | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| PH12022551527A1 (en) * | 2019-12-24 | 2024-01-29 | Merus Nv | Tgf-beta-rii binding proteins |
| RU2750267C1 (ru) * | 2020-02-07 | 2021-06-25 | Общество с ограниченной ответственностью «НАУЧНО-ПРОИЗВОДСТВЕННОЕ ОБЪЕДИНЕНИЕ ИН-ВЕТ» | Рекомбинантный ростовой дифференцировочный фактор роста 11 (GDF11), способ его получения, инъекционный препарат для повышения мышечной массы млекопитающих животных и птицы, а также способ использования препарата |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2194660C (en) * | 1994-07-08 | 2009-09-29 | Se-Jin Lee | Growth differentiation factor-11 |
| US20030167492A1 (en) * | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
| NZ509609A (en) * | 1998-07-28 | 2003-11-28 | Univ Johns Hopkins Med | Disrupting growth differentiation factor-11 (GDF-11) to increase the muscle and bone tissue in animals |
| CN101745112A (zh) * | 2002-07-19 | 2010-06-23 | 艾博特生物技术有限公司 | TNFα相关疾病的治疗 |
| EP1740946B1 (en) * | 2004-04-20 | 2013-11-06 | Genmab A/S | Human monoclonal antibodies against cd20 |
| TW200918553A (en) * | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| US8952130B2 (en) * | 2009-02-24 | 2015-02-10 | The Salk Institute For Biological Studies | Designer ligands of TGF-β superfamily |
| RS66008B1 (sr) * | 2010-03-10 | 2024-10-31 | Genmab As | Monoklonska antitela protiv c-met |
| US9700619B2 (en) * | 2011-11-11 | 2017-07-11 | Duke University | Combination drug therapy for the treatment of solid tumors |
| WO2013148284A1 (en) * | 2012-03-29 | 2013-10-03 | Genentech, Inc. | Antibodies that bind to a pcsk9 cleavage site and methods of use |
| WO2013165972A2 (en) * | 2012-04-30 | 2013-11-07 | Cell Signaling Technology, Inc. | Anti-hepatitis b virus antibodies and use thereof |
| MX388059B (es) * | 2012-11-06 | 2025-03-19 | Scholar Rock Inc | Composiciones y metodos para modular la comunicacion celular. |
| CA2911514A1 (en) * | 2013-05-06 | 2014-11-13 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| WO2016073879A2 (en) * | 2014-11-06 | 2016-05-12 | Scholar Rock, Inc. | Transforming growth factor-related antibodies and uses thereof |
-
2016
- 2016-07-22 JP JP2018502692A patent/JP2018527903A/ja active Pending
- 2016-07-22 CA CA3031430A patent/CA3031430A1/en not_active Abandoned
- 2016-07-22 EP EP16828657.3A patent/EP3324996A4/en not_active Withdrawn
- 2016-07-22 WO PCT/US2016/043712 patent/WO2017015622A2/en not_active Ceased
- 2016-07-22 AU AU2016297248A patent/AU2016297248A1/en not_active Abandoned
- 2016-07-22 US US15/746,467 patent/US20180208648A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527903A5 (enExample) | ||
| US20200079850A1 (en) | Pd-1/lag3 bi-specific antibodies, compositions thereof, and methods of making and using the same | |
| HRP20120477T1 (hr) | Nova anti plgf protutijela | |
| JP2019122405A5 (enExample) | ||
| US11787874B2 (en) | Factor X binders enhancing FX activation | |
| CA2869438A1 (en) | Humanized tau antibody | |
| JP2021501162A5 (enExample) | ||
| JP2017536354A5 (enExample) | ||
| JP2013091655A5 (enExample) | ||
| JP2020536532A5 (enExample) | ||
| RU2012119788A (ru) | Связывающие il-1 белки | |
| JP2017535257A5 (enExample) | ||
| RU2017137010A (ru) | Анти-сеасам6 антитела и их применения | |
| RU2017102514A (ru) | Гуманизированные анти-тау-антитела | |
| TW201323441A (zh) | 抗ｔｎｆ之雙特異性免疫結合物 | |
| EP2377555A3 (en) | Antibodies against vascular endothelial growth factor receptor-1 | |
| JP2016527225A5 (enExample) | ||
| JP2016513664A5 (enExample) | ||
| JP2014503202A (ja) | ＴＮＦ−α結合性タンパク質 | |
| RU2010126078A (ru) | Антитело против nr10 и его применение | |
| JP2018510617A5 (enExample) | ||
| CN106573984A (zh) | 针对mmp9的特异性抗体 | |
| RU2014122990A (ru) | Способы комбинированной терапии с применением молекул, связывающихся с psl и pcrv pseudomonas | |
| JP2024056687A5 (enExample) | ||
| RU2016145277A (ru) | Антитело против igf-1r и его применение в качестве адресующего переносчика для лечения рака |